Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?-Reference-Cited by-同舟云学术

Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?

Published:2017-04 Issue:8 Volume:13 Page:673-677
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Hattinger Claudia M¹,Fanelli Marilù¹,Tavanti Elisa¹,Vella Serena¹,Riganti Chiara²,Picci Piero¹,Serra Massimo¹

Affiliation:

1. Pharmacogenomics & Pharmacogenetics Research Unit, Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute, via di Barbiano 1/10, 40136 Bologna, Italy

2. Department of Oncology & Center for Experimental Research & Medical Studies (CeRMS), University of Torino, via Santena, 5/bis, 10126, Torino, Italy

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon-2016-0519

Reference26 articles.

1. Advances in emerging drugs for osteosarcoma

2. Emerging drugs for high-grade osteosarcoma

3. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma

4. ABC Transporters as Potential Targets for Modulation of Drug Resistance

5. Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking CXCR4–CARM1–YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis;Cancer Science;2024-07-28

2. Rapamycin-induced autophagy in osteosarcoma cells is mediated via the biglycan/Wnt/β-catenin signaling axis;American Journal of Physiology-Cell Physiology;2022-12-01

3. ADCK1 is a potential therapeutic target of osteosarcoma;Cell Death & Disease;2022-11-12

4. Anti-EGFR Targeted Multifunctional I-131 Radio-Nanotherapeutic for Treating Osteosarcoma: In Vitro 3D Tumor Spheroid Model;Nanomaterials;2022-10-08

5. Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models;International Journal of Molecular Sciences;2022-06-08